Niagen Bioscience announces 2026 annual meeting voting results; all directors elected

Niagen Bioscience, Inc.

All 8 director nominees elected: Rubin (28.5M for, 16.8M withheld) and Shahbazi (30.5M for, 14.7M withheld) had significant withhold votes.
Ratification of Crowe LLP as auditor for fiscal 2026 passed with 56.2M for, 2.3M against, 158k abstain.
Advisory say-on-pay proposal approved with 43.2M for, 1.9M against, 172k abstain, and 13.3M broker non-votes.
Broker non-votes of 13.3M were recorded on director elections and say-on-pay but not on auditor ratification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.